These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group. Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975 [TBL] [Abstract][Full Text] [Related]
7. Is concurrent chemoradiation the standard of care for locally advanced non-small cell lung cancer? A review of guidelines and evidence. O'Rourke N; Macbeth F Clin Oncol (R Coll Radiol); 2010 Jun; 22(5):347-55. PubMed ID: 20427167 [TBL] [Abstract][Full Text] [Related]
8. [Chemoradiation therapy: a model for treatment optimization in oncology]. Mornex F; Girard N; Van Houtte P Bull Cancer; 2006 Aug; 93(8):751-60. PubMed ID: 16935779 [TBL] [Abstract][Full Text] [Related]
9. Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer. Belani CP Semin Oncol; 1999 Feb; 26(1 Suppl 2):44-54. PubMed ID: 10190783 [TBL] [Abstract][Full Text] [Related]
10. Concurrent chemoradiation using paclitaxel and carboplatin in locally advanced non-small cell lung cancer. Langer CJ Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):108-16. PubMed ID: 10210549 [TBL] [Abstract][Full Text] [Related]
11. Combined chemo-radiotherapy for locally advanced non-small cell lung cancer: current status and future development. Guida C; Maione P; Rossi A; Bareschino M; Schettino C; Barzaghi D; Elmo M; Gridelli C Crit Rev Oncol Hematol; 2008 Dec; 68(3):222-32. PubMed ID: 18632283 [TBL] [Abstract][Full Text] [Related]
15. Definitive chemoradiation for the treatment of locally advanced non small-cell lung cancer. Blackstock AW; Govindan R J Clin Oncol; 2007 Sep; 25(26):4146-52. PubMed ID: 17827465 [TBL] [Abstract][Full Text] [Related]
16. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935. Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112 [TBL] [Abstract][Full Text] [Related]
17. Reply to: Is concurrent chemoradiation the standard of care for locally advanced non-small cell lung cancer? A review of guidelines and evidence. Faivre-Finn C; Le Pechoux C; Pignon JP; Auperin A Clin Oncol (R Coll Radiol); 2011 Feb; 23(1):62-3; author reply 63-4. PubMed ID: 20934861 [No Abstract] [Full Text] [Related]
18. [Recent changes in the management of advanced non-small cell lung cancer]. Kodama N; Kawahara M; Furuse K Gan To Kagaku Ryoho; 1994 Nov; 21(15):2564-70. PubMed ID: 7979414 [TBL] [Abstract][Full Text] [Related]
19. Pattern of failure following chemoradiation for locally advanced non-small cell lung cancer: potential role for stereotactic body radiotherapy. Nguyen NP; Bishop M; Borok TJ; Welsh J; Hamilton R; Cohen D; Nguyen LM; Vincent VH Anticancer Res; 2010 Mar; 30(3):953-61. PubMed ID: 20393019 [TBL] [Abstract][Full Text] [Related]
20. [Combination of chemotherapy and radiotherapy for locally advanced non-small cell lung cancer]. Fournel P Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S94-100. PubMed ID: 18235400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]